These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12070536)

  • 41. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
    Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K; Wakino S; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2005 Nov; 99(3):221-7. PubMed ID: 16293936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
    Yokoyama T; Ichihara K; Abiko Y
    Fundam Clin Pharmacol; 1997; 11(3):245-51. PubMed ID: 9243256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
    Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
    Hu C; Mori T; Lu Y; Guo Q; Sun Y; Yoneki Y; Ohsaki Y; Nakamichi T; Oba I; Sato E; Ogawa S; Dickinson BC; Chang CJ; Miyata T; Sato H; Ito S
    J Hypertens; 2012 Aug; 30(8):1620-31. PubMed ID: 22688264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-type Ca2+ channels promote oxygenation-induced closure of the rat ductus arteriosus not only by vasoconstriction but also by neointima formation.
    Akaike T; Jin MH; Yokoyama U; Izumi-Nakaseko H; Jiao Q; Iwasaki S; Iwamoto M; Nishimaki S; Sato M; Yokota S; Kamiya Y; Adachi-Akahane S; Ishikawa Y; Minamisawa S
    J Biol Chem; 2009 Sep; 284(36):24025-34. PubMed ID: 19567868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-type Ca channel blockade as a determinant of kidney protection.
    Hayashi K; Homma K; Wakino S; Tokuyama H; Sugano N; Saruta T; Itoh H
    Keio J Med; 2010; 59(3):84-95. PubMed ID: 20881449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension.
    Tomino Y
    Curr Hypertens Rev; 2013 May; 9(2):108-14. PubMed ID: 23971692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
    Masumiya H; Tanaka H; Shigenobu K
    Eur J Pharmacol; 1997 Sep; 335(1):15-21. PubMed ID: 9371541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M; Ogawa T; Han WH; Takabatake T
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.
    Sripetchwandee J; Khamseekaew J; Svasti S; Srichairatanakool S; Fucharoen S; Chattipakorn N; Chattipakorn SC
    Life Sci; 2019 Dec; 239():116878. PubMed ID: 31669736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
    Jin H; Sato R; Higashino R; Fukuda Y; Kurimoto T; Tamaki H
    Biol Pharm Bull; 1997 Feb; 20(2):196-200. PubMed ID: 9057986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
    Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs.
    Yokoyama T; Ichihara K; Abiko Y
    Jpn J Pharmacol; 1996 Dec; 72(4):291-7. PubMed ID: 9015737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
    Yokoyama T; Fujikura N; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
    Ikeda K; Saito T; Tojo K
    Tohoku J Exp Med; 2011 Aug; 224(4):263-71. PubMed ID: 21757861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible requirement of phosphonate moiety for efonidipine effects on the sino-atrial node action potential.
    Masumiya H; Matsuda T; Tanaka Y; Tanaka H; Shigenobu K
    Life Sci; 2000; 66(16):PL239-44. PubMed ID: 10794505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.